FULC Valuation
Fulcrum Therapeutics Inc
$
5.620
- Overview
- Forecast
- Valuation
FULC Relative Valuation
FULC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FULC is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.00
P/B
Median3y
1.45
Median5y
2.30
0.00
FCF Yield
Median3y
-23.48
Median5y
-19.64
Competitors Valuation Multiple
The average P/S ratio for FULC's competitors is 2.28, providing a benchmark for relative valuation. Fulcrum Therapeutics Inc Corp (FULC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
DCGO
DocGo Inc
2.310
USD
+5.00%
TCMD
Tactile Systems Technology Inc
14.080
USD
+1.81%
TBPH
Theravance Biopharma Inc
10.370
USD
-0.19%
FLX
BingEx Ltd
2.290
USD
+2.69%
ITIC
Investors Title Co
240.680
USD
+3.26%
CYH
Community Health Systems Inc
2.830
USD
+2.54%
SNDA
Sonida Senior Living Inc
24.080
USD
+3.70%
RWAY
Runway Growth Finance Corp
9.210
USD
+1.43%
METC
Ramaco Resources Inc
10.000
USD
+0.50%
MEI
Methode Electronics Inc
6.680
USD
+4.70%
FAQ
Is Fulcrum Therapeutics Inc (FULC) currently overvalued or undervalued?
Fulcrum Therapeutics Inc (FULC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 55.20. The fair price of Fulcrum Therapeutics Inc (FULC) is between to according to relative valuation methord.
What is Fulcrum Therapeutics Inc (FULC) fair value?
How does FULC's valuation metrics compare to the industry average?
What is the current P/B ratio for Fulcrum Therapeutics Inc (FULC) as of May 03 2025?
What is the current FCF Yield for Fulcrum Therapeutics Inc (FULC) as of May 03 2025?
What is the current Forward P/E ratio for Fulcrum Therapeutics Inc (FULC) as of May 03 2025?